Industry Reps Meet With FDA Leadership To Talk Transparency
This article was originally published in The Gray Sheet
Executive Summary
FDA is too slow to provide necessary information to companies, whether through guidance or responses to industry inquiries, medical device reps said during a recent listening session with the agency's Transparency Task Force
You may also be interested in...
FDA Unveils 21 Policy Changes To Increase Transparency With Public
FDA may publicly disclose more information on specific devices prior to marketing approval under a May 19 proposal to increase transparency
FDA Unveils 21 Policy Changes To Increase Transparency With Public
FDA may publicly disclose more information on specific devices prior to marketing approval under a May 19 proposal to increase transparency
FDA Is Growing Reluctant To Communicate With Companies, Industry Charges
FDA regulators have become more reluctant to cooperate with device sponsors, industry reps maintain